Synapse preservation and decreased glial reactions following ventral root crush (VRC) and treatment with 4-hydroxy-tempo (TEMPOL)

J Neurosci Res. 2019 Apr;97(4):520-534. doi: 10.1002/jnr.24365. Epub 2018 Dec 14.

Abstract

Astrogliosis and microglial reactions are correlated with the formation of scar tissue and synapse loss. 4-hydroxy-tempo (TEMPOL) is a reactive oxygen species scavenger with proven neuroprotective efficacy in experimental models of traumatic injury and cerebral ischemia. TEMPOL has not, however, been applied following ventral root lesions, which are particularly correlated with the degeneration of spinal motoneurons following brachial plexus injuries. Thus, the present study investigated the effects of TEMPOL on motoneurons and adjacent glial reactions, with a particular focus on the preservation of excitatory and inhibitory spinal circuits. Adult female Sprague Dawley rats were subjected to ventral root crush (VRC) at the lumbar intumescence. Animals were divided into the following experimental groups: (a) VRC-saline treatment; (b) VRC-TEMPOL treatment (12 mg/kg, n = 5), and (c) VRC-TEMPOL treatment (250 mg/kg, n = 5). The spinal cord tissue located contralateral to the lesion was used as the control. Fourteen days after lesioning, the rats were euthanized and the spinal cords were removed for motoneuron counting and immunolabeling with glial (GFAP and Iba-1) and synapse markers (synaptophysin, VGLUT-1, and GAD65). Although TEMPOL did not exert neuroprotective effects at the studied concentrations, the modulation of glial reactions was significant at higher doses. Thus, synaptophysin staining was preserved and, in particular, VGLUT-1-positive inputs were maintained, thereby indicating that TEMPOL preserved proprioceptive glutamatergic inputs without exacerbating the rate of motoneuron degeneration. Consequently, its administration with other efficient neuroprotective substances may significantly improve the outcomes following spinal cord lesioning.

Keywords: TEMPOL; gliosis; inflammation; motoneuron; spinal cord; ventral root lesion.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antioxidants
  • Cyclic N-Oxides / pharmacology*
  • Female
  • Glial Fibrillary Acidic Protein / metabolism
  • Gliosis
  • Hydroxylamine / pharmacology*
  • Motor Neurons / pathology
  • Neuroglia / drug effects*
  • Neuroprotective Agents / pharmacology*
  • Rats
  • Rats, Sprague-Dawley
  • Spinal Cord Lateral Horn / metabolism
  • Spinal Nerve Roots / injuries*
  • Spinal Nerve Roots / metabolism*
  • Spinal Nerve Roots / pathology
  • Synapses / drug effects*
  • Synaptophysin / metabolism
  • Vesicular Glutamate Transport Protein 1 / metabolism

Substances

  • Antioxidants
  • Cyclic N-Oxides
  • GFAP protein, rat
  • Glial Fibrillary Acidic Protein
  • Neuroprotective Agents
  • Slc17a7 protein, rat
  • Synaptophysin
  • Vesicular Glutamate Transport Protein 1
  • Hydroxylamine
  • TEMPOL-H